查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600986

颅内动脉瘤市场：按类型、适应症和最终用户划分 - 全球预测 2025-2030

Intracranial Aneurysm Market by Type (Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters), Indication (Ruptured Aneurysm, Unruptured Aneurysm), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年颅内动脉瘤市值为13.2亿美元，预计2024年将达16亿美元，复合年增长率为22.16%，到2030年将达到53.8亿美元。

颅内动脉瘤是指大脑动脉异常扩张，由于潜在的破裂而造成严重的健康风险，导致出血性中风等严重併发症。高血压、吸烟和酒精成瘾等生活方式相关因素的增加推动了对先进诊断和治疗解决方案的需求。由于神经影像学和微创手术技术的创新，颅内动脉瘤市场正在扩大。主要应用在医疗保健领域，特别是神经诊断中心和医院，重点是血管内卷取和血流转向支架。从最终用途的角度来看，主要相关人员是医疗保健提供者、研究机构和设备製造商。新兴国家的技术进步、医疗保健支出的增加以及医疗保健服务范围的扩大对市场成长产生了重大影响。此外，世界人口老化以及血管疾病的高盛行率也带来了进一步增长的潜力。然而，治疗成本上升、监管核准严格以及欠发达地区认知度低等挑战可能会阻碍市场扩张。为了抓住新的机会，公司必须投资研发，以开发具有成本效益和高效的治疗方法，并与医疗机构合作进行临床试验和教育倡议。最新的机会在于人工智慧主导的诊断工具和患者特定治疗计划的兴起，这些可以增强精准医疗。然而，低收入地区的经济限制和高昂的发展成本仍然是主要障碍。创新研究领域包括生物分解性支架的开发、用于早期检测的增强生物资讯学以及混合成像技术。市场主要由技术进步和策略联盟驱动，因此需要积极主动的策略联盟和持续创新，以应对不断变化的市场动态和患者需求。

主要市场统计
基准年[2023] 13.2亿美元
预测年份 [2024] 16亿美元
预测年份 [2030] 53.8亿美元
复合年增长率（%） 22.16%

市场动态：快速发展的颅内动脉瘤市场的关键市场洞察

供需的动态交互作用正在改变颅内动脉瘤市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于生活方式的改变，脑血管疾病的盛行率增加
    • 倾向微创手术
    • 改善颅内动脉瘤的诊断
  • 市场限制因素
    • 与治疗相关的副作用和治疗费用上涨
  • 市场机会
    • 活性化研发活动并推出创新技术产品
    • 增加血管内卷取的可能性
  • 市场挑战
    • 有关手术时机和麻醉诱导的问题

波特五力：驾驭颅内动脉瘤市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解颅内动脉瘤市场的外部影响

外部宏观环境因素在塑造颅内动脉瘤市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解颅内动脉瘤市场的竞争状况

颅内动脉瘤市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵颅内动脉瘤市场供应商的绩效评估

FPNV定位矩阵是评估颅内动脉瘤市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活型态改变导致脑血管疾病发生率增加
      • 颅内动脉瘤微创治疗趋势
      • 改善颅内动脉瘤的诊断
    • 抑制因素
      • 与治疗相关的副作用和治疗费用上涨
    • 机会
      • 活性化研发活动并推出创新技术产品
      • 血管内弹簧圈栓塞的潜力不断增加
    • 任务
      • 有关手术时机和麻醉诱导的问题
  • 市场区隔分析
    • 类型：对微创技术的需求，例如针对较小囊状动脉瘤的血管内弹簧圈栓塞术
    • 最终用户：寻求早期筛检和诊断服务的诊所之间的患者流量增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章颅内动脉瘤市场：依类型

  • 动脉闭塞和搭桥
  • 血管内弹簧圈栓塞术
  • 分流器
  • 手术夹闭

第七章颅内动脉瘤市场（按适应症）

  • 动脉瘤破裂
  • 未破裂动脉瘤

第八章颅内动脉瘤市场：依最终用户分类

  • 诊所
  • 医院

第九章 北美及南美颅内动脉瘤市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区颅内动脉瘤市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲颅内动脉瘤市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Evasc 宣布临床里程碑并计划与德国子公司扩大欧洲业务
    • OU研究人员设计设备以改善脑动脉瘤的治疗

公司名单

  • Adeor Medical AG
  • Oxford Endovascular Ltd.
  • F. Hoffmann-La Roche AG
  • Mizuho Medical Co,Ltd.
  • Penumbra, Inc.
  • Acandis GmbH
  • Medtronic PLC
  • Abbott Laboratories
  • Integra Lifesciences Holdings Corporation
  • B. Braun Melsungen AG
  • Cardiatis, SA
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Microport Scientific Corporation
  • Evasc Medical Systems Corp
  • Balt Extrusion SA
  • Terumo Corporation
  • Abbvie Inc.
  • Bayer AG
  • Stryker Corporation
  • Merck & Co., Inc.
  • Kaneka Corporation
Product Code: MRR-A339DAEF9EC7

The Intracranial Aneurysm Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 22.16%, to USD 5.38 billion by 2030.

Intracranial aneurysms refer to the abnormal dilation of arteries within the brain, posing a significant health risk due to potential rupture, leading to severe complications like hemorrhagic stroke. The increasing incidence of lifestyle-related factors such as hypertension, smoking, and alcoholism drives the necessity for advanced diagnostic and therapeutic solutions. With innovations in neuroimaging technologies and minimally invasive surgical techniques, the intracranial aneurysm market is expanding. The primary applications are in the healthcare sector, particularly in neurodiagnostic centers and hospitals, focusing on endovascular coiling and flow-diverting stents. From an end-use perspective, healthcare providers, research institutions, and device manufacturers represent key stakeholders. Market growth is significantly influenced by technological advancements, increasing healthcare expenditures, and expanding access to healthcare services in emerging economies. Additionally, the aging global population, which experiences a higher prevalence of vascular disorders, presents further growth potential. However, challenges such as high costs of treatment, stringent regulatory approvals, and limited awareness in underdeveloped regions can impede market expansion. To capture emerging opportunities, companies should invest in R&D to develop cost-effective and efficient treatment modalities and partner with medical institutions for clinical trials and educational initiatives. The latest opportunities lie in the rise of AI-driven diagnostic tools and patient-specific treatment planning, which can enhance precision medicine. Nevertheless, economic constraints in low-income regions and high development costs remain significant hurdles. Innovative areas for research include the development of biodegradable stents, enhanced bioinformatics for early detection, and hybrid imaging techniques. The market is predominantly driven by technological advancements and strategic collaborations, thus necessitating a proactive approach in strategic partnerships and continuous innovation to cater to shifting market dynamics and patient needs.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 5.38 billion
CAGR (%) 22.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Aneurysm Market

The Intracranial Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
    • Inclination for Minimally Invasive Intracranial Aneurysm Procedures
    • Improved Diagnosis for Intracranial Aneurysm
  • Market Restraints
    • Side Effects Associated with Therapies and High Cost of Treatments
  • Market Opportunities
    • Rise in Research and Development Activities and Introduction of Innovative Technology Products
    • Rising Potential for Endovascular Coiling
  • Market Challenges
    • Issues Related to Timing of Surgery and Anesthetic Induction

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Aneurysm Market

A detailed market share analysis in the Intracranial Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Adeor Medical AG, Oxford Endovascular Ltd., F. Hoffmann-La Roche AG, Mizuho Medical Co,Ltd., Penumbra, Inc., Acandis GmbH, Medtronic PLC, Abbott Laboratories, Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, Cardiatis, S.A., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Pfizer Inc., Microport Scientific Corporation, Evasc Medical Systems Corp, Balt Extrusion S.A., Terumo Corporation, Abbvie Inc., Bayer AG, Stryker Corporation, Merck & Co., Inc., and Kaneka Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters, and Surgical Clipping.
  • Based on Indication, market is studied across Ruptured Aneurysm and Unruptured Aneurysm.
  • Based on End User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
      • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
      • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
      • 5.1.3.2. Rising Potential for Endovascular Coiling
    • 5.1.4. Challenges
      • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
    • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Intracranial Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Artery Occlusion & Bypass
  • 6.3. Endovascular Coiling
  • 6.4. Flow Diverters
  • 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

  • 7.1. Introduction
  • 7.2. Ruptured Aneurysm
  • 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
    • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

Companies Mentioned

  • 1. Adeor Medical AG
  • 2. Oxford Endovascular Ltd.
  • 3. F. Hoffmann-La Roche AG
  • 4. Mizuho Medical Co,Ltd.
  • 5. Penumbra, Inc.
  • 6. Acandis GmbH
  • 7. Medtronic PLC
  • 8. Abbott Laboratories
  • 9. Integra Lifesciences Holdings Corporation
  • 10. B. Braun Melsungen AG
  • 11. Cardiatis, S.A.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Bristol-Myers Squibb Company
  • 14. Pfizer Inc.
  • 15. Microport Scientific Corporation
  • 16. Evasc Medical Systems Corp
  • 17. Balt Extrusion S.A.
  • 18. Terumo Corporation
  • 19. Abbvie Inc.
  • 20. Bayer AG
  • 21. Stryker Corporation
  • 22. Merck & Co., Inc.
  • 23. Kaneka Corporation

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023